CIE 28077-2016 Photocarcinogenesis action spectrum (non-melanoma skin cancers) (Second Edition).pdf

1、Photocarcinogenesis action spectrum (non-melanoma skin cancers)Spectre daction de la photocarcinogense (cancers de la peau hors mlanome)INTERNATIONAL STANDARDISO/CIE28077Reference numberISO/CIE 28077:2016(E)Second edition2016-10-01 ISO/CIE 2016ii ISO/CIE 2016 All rights reservedCOPYRIGHT PROTECTED D

2、OCUMENT ISO/CIE 2016, Published in SwitzerlandAll rights reserved. Unless otherwise specified, no part of this publication may be reproduced or utilized otherwise in any form or by any means, electronic or mechanical, including photocopying, or posting on the internet or an intranet, without prior w

3、ritten permission. Permission can be requested from either ISO at the address below or ISOs member body in the country of the requester.ISO copyright office CIE Central BureauCh. de Blandonnet 8 CP 401 Babenbergerstrae 9/9ACH-1214 Vernier, Geneva, Switzerland A-1010 Vienna, AustriaTel. +41 22 749 01

4、 11 Tel. +43 1 714 3187Fax +41 22 749 09 47 copyrightiso.org ciecbcie.co.atwww.iso.org www.cie.co.atISO/CIE 28077:2016(E)ISO/CIE 28077:2016(E)Foreword ivIntroduction v1 Scope . 12 Normative references 13 Terms, definitions, symbols and abbreviations . 13.1 Terms and definitions . 13.2 Symbols and ab

5、breviations 14 The action spectrum for photocarcinogenesis of non-melanoma skin cancers . 15 Tabulated and graphic values . 2Bibliography 7 ISO/CIE 2016 All rights reserved iiiContents PageISO/CIE 28077:2016(E)ForewordISO (the International Organization for Standardization) is a worldwide federation

6、 of national standards bodies (ISO member bodies). The work of preparing International Standards is normally carried out through ISO technical committees. Each member body interested in a subject for which a technical committee has been established has the right to be represented on that committee.

7、International organizations, governmental and non-governmental, in liaison with ISO, also take part in the work. ISO collaborates closely with the International Electrotechnical Commission (IEC) on all matters of electrotechnical standardization.The procedures used to develop this document and those

8、 intended for its further maintenance are described in the ISO/IEC Directives, Part 1. In particular the different approval criteria needed for the different types of ISO documents should be noted. This document was drafted in accordance with the editorial rules of the ISO/IEC Directives, Part 2 (se

9、e www.iso.org/directives).Attention is drawn to the possibility that some of the elements of this document may be the subject of patent rights. ISO shall not be held responsible for identifying any or all such patent rights. Details of any patent rights identified during the development of the docum

10、ent will be in the Introduction and/or on the ISO list of patent declarations received (see www.iso.org/patents).Any trade name used in this document is information given for the convenience of users and does not constitute an endorsement.For an explanation on the meaning of ISO specific terms and e

11、xpressions related to conformity assessment, as well as information about ISOs adherence to the World Trade Organization (WTO) principles in the Technical Barriers to Trade (TBT) see the following URL: www.iso.org/iso/foreword.html.ISO/CIE 28077 was prepared by CIE Technical Committee 6-32, Action S

12、pectrum for Photocarcinogenesis, as CIE S 019. The committee responsible for this document is ISO/TC 274, Light and lighting.This second edition cancels and replaces the first edition (ISO 28077:2006), of which it constitutes a minor revision.iv ISO/CIE 2016 All rights reservedISO/CIE 28077:2016(E)I

13、ntroductionSolar ultraviolet radiation (UVR) is recognized as a major cause of non-melanoma skin cancer in human beings. Skin cancer occurs most frequently in the most heavily exposed areas and correlates with degree of outdoor exposure. Describing the relationship of exposure (dose) to risk (skin c

14、ancer) requires the availability of a biological hazard function or action spectrum for photocarcinogenesis. This document proposes the adoption of an action spectrum (weighting function) derived from experimental laboratory data and modified to estimate the non-melanoma tumour response in human ski

15、n. The experimental data are sufficient for estimating effectiveness down to about 250 nm, but experimental data are not sufficient for specifying effectiveness above 400 nm. ISO/CIE 2016 All rights reserved vPhotocarcinogenesis action spectrum (non-melanoma skin cancers)1 ScopeThis document specifi

16、es the action spectrum for photocarcinogenesis of non-melanoma skin cancers.2 Normative referencesThere are no normative references in this document.3 Terms, definitions, symbols and abbreviationsFor the purposes of this document, the terms and definitions given in CIE S 017/E:2011 and the following

17、 terms and definitions, symbols and abbreviations apply.ISO and IEC maintain terminological databases for use in standardization at the following addresses: IEC Electropedia: available at http:/www.electropedia.org/ ISO Online browsing platform: available at http:/www.iso.org/obp3.1 Terms and defini

18、tions3.1.1ultraviolet radiationUVRradiation for which the wavelengths are shorter than those for visible radiationNote 1 to entry: The range between 100 nm and 400 nm is commonly subdivided into: UV-A: 315 nm to 400 nm; UV-B: 280 nm to 315 nm; UV-C: 100 nm to 280 nm.SOURCE: CIE S 017/E:2011, Term 17

19、-1367, modified Notes 2 and 3 have been omitted.3.2 Symbols and abbreviationsSCUP Skin Cancer Utrecht-Philadelphia (an action spectrum proposed in Reference 1)SCUP-m designates the original SCUP action spectrum, based entirely on mouse dataSCUP-h designates a proposed action spectrum estimated by co

20、rrecting for differences in UV transmissions between human and murine epidermisUV-A1 wavelength range from 340 nm to 400 nmUV-A2 wavelength range from 315 nm to 340 nm4 The action spectrum for photocarcinogenesis of non-melanoma skin cancersThe effectiveness of ultraviolet radiation in causing photo

21、carcinogenesis of non-melanoma skin cancers has been studied for many years1-16. The action spectrum defined in this document was first published by the CIE as the product of research by CIE Technical Committee 6-32, as CIE 138/2.16The document stated the following recognized limitations to this act

22、ion spectrum:INTERNATIONAL STANDARD ISO/CIE 28077:2016(E) ISO/CIE 2016 All rights reserved 1ISO/CIE 28077:2016(E)“The UV-A1 part (340 nm400 nm) of the SCUP action spectra has large margins of uncertainty (from 10 %20 % at 340 nm to an order of magnitude at 390 nm); the minimum at 350 nm and especial

23、ly the secondary maximum at 380 nm are not well defined. Recent biochemical data do, however, indicate that action spectra for some types of DNA damage from reactive oxygen species, such as released by UV-A, show a minimum around 350 nm.Exploiting this as yet ill-defined fine structure in the UV-A1

24、region of the SCUP-h action spectrum (e.g. for optimizing commercial tanning lamps) would be unjustified. Because the Committee report should provide a standard for risk assessment in regulatory applications, its recommendation eliminates the uncertainty associated with the fine structure of the SCU

25、P-h action spectrum. Committee consensus involved flattening the plateau at the 340 nm level. Mathematically, this results in the least available deterioration of the curve fit to the actual experimental data (the Chi-square of the fit goes up from 13,7 to 18,2 with 7 degrees of freedom).”16NOTE An

26、action spectrum based on the Utrecht-Philadelphia collaboration bears the acronym “SCUP” (for Skin Cancer Utrecht Philadelphia). “SCUP-m” is the best fit to the mouse data, using a computer polynomial program. Based on SCUP-m, a SCUP-h action spectrum (“-h” for human) was estimated by correcting for

27、 differences in UV transmissions between human and murine epidermis.17The action spectrum for photocarcinogenesis is based principally on experimental data from mice; comparable data are obviously not available from humans. The limits of this extrapolation are yet to be determined. Based on all thes

28、e considerations, a standard action spectrum for photocarcinogenesis is provided in Table 1 and shown in Figure 1.5 Tabulated and graphic valuesTable 1 Action spectrum for photocarcinogenesis (non-melanoma skin cancer)Wavelength / nmEffectiveness (decimal) Effectiveness (exponential)250 0,010 900 1,

29、090 00E-02251 0,011 139 1,113 90E-02252 0,011 383 1,138 30E-02253 0,011 633 1,163 30E-02254 0,011 888 1,188 80E-02255 0,012 158 1,215 80E-02256 0,012 435 1,243 50E-02257 0,012 718 1,271 80E-02258 0,013 007 1,300 70E-02259 0,013 303 1,330 30E-02260 0,013 605 1,360 50E-02261 0,013 915 1,391 50E-02262

30、0,014 231 1,423 10E-02263 0,014 555 1,455 50E-02264 0,014 886 1,488 60E-02265 0,015 225 1,522 50E-02266 0,015 571 1,557 10E-02267 0,015 925 1,592 50E-02268 0,016 287 1,628 70E-02269 0,016 658 1,665 80E-02270 0,017 037 1,703 70E-02271 0,017 424 1,742 40E-022 ISO/CIE 2016 All rights reservedISO/CIE 28

31、077:2016(E)Wavelength / nmEffectiveness (decimal) Effectiveness (exponential)272 0,017 821 1,782 10E-02273 0,018 226 1,822 60E-02274 0,018 641 1,864 10E-02275 0,019 065 1,906 50E-02276 0,019 498 1,949 80E-02277 0,019 942 1,994 20E-02278 0,020 395 2,039 50E-02279 0,020 859 2,085 90E-02280 0,021 334 2

32、,133 40E-02281 0,025 368 2,536 80E-02282 0,030 166 3,016 60E-02283 0,035 871 3,587 10E-02284 0,057 388 5,738 80E-02285 0,088 044 8,804 40E-02286 0,129 670 1,296 70E-01287 0,183 618 1,836 18E-01288 0,250 586 2,505 86E-01289 0,330 048 3,300 48E-01290 0,420 338 4,203 38E-01291 0,514 138 5,141 38E-01292

33、 0,609 954 6,099 54E-01293 0,703 140 7,031 40E-01294 0,788 659 7,886 59E-01295 0,861 948 8,619 48E-01296 0,919 650 9,196 50E-01297 0,958 965 9,589 65E-01298 0,988 917 9,889 17E-01299 1,000 000 1,000 00E+00300 0,991 996 9,919 96E-01301 0,967 660 9,676 60E-01302 0,929 095 9,290 95E-01303 0,798 410 7,9

34、84 10E-01304 0,677 339 6,773 39E-01305 0,567 466 5,674 66E-01306 0,470 257 4,702 57E-01307 0,385 911 3,859 11E-01308 0,313 889 3,138 89E-01309 0,253 391 2,533 91E-01310 0,203 182 2,031 82E-01311 0,162 032 1,620 32E-01312 0,128 671 1,286 71E-01313 0,101 794 1,017 94E-01314 0,079 247 7,924 70E-02Table

35、 1 (continued) ISO/CIE 2016 All rights reserved 3ISO/CIE 28077:2016(E)Wavelength / nmEffectiveness (decimal) Effectiveness (exponential)315 0,061 659 6,165 90E-02316 0,047 902 4,790 20E-02317 0,037 223 3,722 30E-02318 0,028 934 2,893 40E-02319 0,022 529 2,252 90E-02320 0,017 584 1,758 40E-02321 0,01

36、3 758 1,375 80E-02322 0,010 804 1,080 40E-02323 0,008 525 8,525 00E-03324 0,006 756 6,756 00E-03325 0,005 385 5,385 00E-03326 0,004 316 4,316 00E-03327 0,003 483 3,483 00E-03328 0,002 830 2,830 00E-03329 0,002 316 2,316 00E-03330 0,001 911 1,911 00E-03331 0,001 590 1,590 00E-03332 0,001 333 1,333 00

37、E-03333 0,001 129 1,129 00E-03334 0,000 964 9,640 00E-04335 0,000 810 8,100 00E-04336 0,000 688 6,880 00E-04337 0,000 589 5,890 00E-04338 0,000 510 5,100 00E-04339 0,000 446 4,460 00E-04340 0,000 394 3,940 00E-04341 0,000 394 3,940 00E-04342 0,000 394 3,940 00E-04343 0,000 394 3,940 00E-04344 0,000

38、394 3,940 00E-04345 0,000 394 3,940 00E-04346 0,000 394 3,940 00E-04347 0,000 394 3,940 00E-04348 0,000 394 3,940 00E-04349 0,000 394 3,940 00E-04350 0,000 394 3,940 00E-04351 0,000 394 3,940 00E-04352 0,000 394 3,940 00E-04353 0,000 394 3,940 00E-04354 0,000 394 3,940 00E-04355 0,000 394 3,940 00E-

39、04356 0,000 394 3,940 00E-04357 0,000 394 3,940 00E-04Table 1 (continued)4 ISO/CIE 2016 All rights reservedISO/CIE 28077:2016(E)Wavelength / nmEffectiveness (decimal) Effectiveness (exponential)358 0,000 394 3,940 00E-04359 0,000 394 3,940 00E-04360 0,000 394 3,940 00E-04361 0,000 394 3,940 00E-0436

40、2 0,000 394 3,940 00E-04363 0,000 394 3,940 00E-04364 0,000 394 3,940 00E-04365 0,000 394 3,940 00E-04366 0,000 394 3,940 00E-04367 0,000 394 3,940 00E-04368 0,000 394 3,940 00E-04369 0,000 394 3,940 00E-04370 0,000 394 3,940 00E-04371 0,000 394 3,940 00E-04372 0,000 394 3,940 00E-04373 0,000 394 3,

41、940 00E-04374 0,000 394 3,940 00E-04375 0,000 394 3,940 00E-04376 0,000 394 3,940 00E-04377 0,000 394 3,940 00E-04378 0,000 394 3,940 00E-04379 0,000 394 3,940 00E-04380 0,000 394 3,940 00E-04381 0,000 394 3,940 00E-04382 0,000 394 3,940 00E-04383 0,000 394 3,940 00E-04384 0,000 394 3,940 00E-04385

42、0,000 394 3,940 00E-04386 0,000 394 3,940 00E-04387 0,000 394 3,940 00E-04388 0,000 394 3,940 00E-04389 0,000 394 3,940 00E-04390 0,000 394 3,940 00E-04391 0,000 394 3,940 00E-04392 0,000 394 3,940 00E-04393 0,000 394 3,940 00E-04394 0,000 394 3,940 00E-04395 0,000 394 3,940 00E-04396 0,000 394 3,94

43、0 00E-04397 0,000 394 3,940 00E-04398 0,000 394 3,940 00E-04399 0,000 394 3,940 00E-04400 0,000 394 3,940 00E-04Table 1 (continued) ISO/CIE 2016 All rights reserved 5ISO/CIE 28077:2016(E)KeyX wavelength (nm)Y relative effectivenessFigure 1 Action spectrum for photocarcinogenesis: non-melanoma skin cancer6 ISO/CIE 2016 All rights reservedISO/CIE 28077:2016(E)Bibliography1 De Gruijl F.R., 17.180.20Price based on 7 pages